Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report) shares rose 6.5% during trading on Monday . The stock traded as high as $19.93 and last traded at $19.93. Approximately 1,177 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 79,393 shares. The stock had previously closed at $18.72.
Analyst Ratings Changes
Separately, JPMorgan Chase & Co. initiated coverage on Ascentage Pharma Group International in a report on Thursday, March 27th. They set an "overweight" rating on the stock.
Get Our Latest Stock Analysis on AAPG
Ascentage Pharma Group International Trading Up 3.1 %
The firm has a 50 day simple moving average of $20.06.
Ascentage Pharma Group International Company Profile
(
Get Free Report)
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Featured Articles
Before you consider Ascentage Pharma Group International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascentage Pharma Group International wasn't on the list.
While Ascentage Pharma Group International currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
